Abstract:Ensuring the safety and efficacy of chemical compounds is crucial in small-molecule drug development. In the later stages of drug development, toxic compounds pose a significant challenge, losing valuable resources and time. Early and accurate prediction of compound toxicity using deep learning models offers a promising solution to mitigate these risks during drug discovery. In this study, we present the development of several deep-learning models aimed at evaluating different types of compound toxicity, including acute toxicity, carcinogenicity, hERG_cardiotoxicity (the human ether-a-go-go related gene caused cardiotoxicity), hepatotoxicity, and mutagenicity. To address the inherent variations in data size, label type, and distribution across different types of toxicity, we employed diverse training strategies. Our first approach involved utilizing a graph convolutional network (GCN) regression model to predict acute toxicity, which achieved notable performance with Pearson R 0.76, 0.74, and 0.65 for intraperitoneal, intravenous, and oral administration routes, respectively. Furthermore, we trained multiple GCN binary classification models, each tailored to a specific type of toxicity. These models exhibited high area under the curve (AUC) scores, with an impressive AUC of 0.69, 0.77, 0.88, and 0.79 for predicting carcinogenicity, hERG_cardiotoxicity, mutagenicity, and hepatotoxicity, respectively. Additionally, we have used the approved drug dataset to determine the appropriate threshold value for the prediction score in model usage. We integrated these models into a virtual screening pipeline to assess their effectiveness in identifying potential low-toxicity drug candidates. Our findings indicate that this deep learning approach has the potential to significantly reduce the cost and risk associated with drug development by expediting the selection of compounds with low toxicity profiles. Therefore, the models developed in this study hold promise as critical tools for early drug candidate screening and selection.

Learning with uncertainty to accelerate the discovery of histone lysine-specific demethylase 1A (KDM1A/LSD1) inhibitors

An Adaptive Graph Learning Method for Automated Molecular Interactions and Properties Predictions

An Uncertainty-Guided Deep Learning Method Facilitates Rapid Screening of CYP3A4 Inhibitors

Evidential Deep Learning for Guided Molecular Property Prediction and Discovery

Evaluating uncertainty-based active learning for accelerating the generalization of molecular property prediction

Understanding the Performance of Knowledge Graph Embeddings in Drug Discovery

Inactive-enriched machine-learning models exploiting patent data improve structure-based virtual screening for PDL1 dimerizers

Kinome-wide polypharmacology profiling of small molecules by multi-task graph isomorphism network approach

Consensus holistic virtual screening for drug discovery: a novel machine learning model approach

Machine learning on DNA-encoded library count data using an uncertainty-aware probabilistic loss function

Identification of Novel Selective Lysine‐Specific Demethylase 1 (LSD1) Inhibitors Using a Pharmacophore‐Based Virtual Screening Combined with Docking

Integrated Molecular Modeling and Machine Learning for Drug Design

Generating and screening de novo compounds against given targets using ultrafast deep learning models as core components

Combating small molecule aggregation with machine learning

Data-augmented machine learning scoring functions for virtual screening of YTHDF1 m6A reader protein

Exploration on Learning Molecular Docking with Deep Learning Models

SYNERGY OF ADVANCED MACHINE LEARNING AND DEEP NEURAL NETWORKS WITH CONSENSUS MOLECULAR DOCKING FOR ENHANCED POTENCY PREDICTION OF ALK INHIBITORS

Discovery of novel ULK1 inhibitors through machine learning-guided virtual screening and biological evaluation

Docking Score ML: Target-Specific Machine Learning Models Improving Docking-Based Virtual Screening in 155 Targets

Electron-density informed effective and reliable de novo molecular design and lead optimization with ED2Mol

A deep learning based multi-model approach for predicting drug-like chemical compound's toxicity